Search Orphan Drug Designations and Approvals
-
Generic Name: | haptoglobin (Hp1-1), (Human) |
---|---|
Date Designated: | 10/12/2021 |
Orphan Designation: | Treatment of subarachnoid hemorrhage |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
CSL Behring 1020 First Avenue PO Box 61501 King of Prussia, Pennsylvania 19406-0901 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-